Schedule 13D ownership disclosure

Onconova Therapeutics Inc

Security class unavailable · CUSIP: 68232V306

Event date: 2016-07-29

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
1,410,345
Percent of class
Unavailable

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-16-138997
Form type
SC 13D/A
Filer
Hoffman Michael B
CIK
CIK 1290208
Filed
Aug 11, 2016
Reporting period
Jul 29, 2016
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub